{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:05:58Z","timestamp":1792735558911,"version":"4.5.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Despite a significant reduction in the global HIV disease prevalence in recent years, children under 15\u202fyears of age still account for 3% of people living with HIV, 9% of new incidence, and 12% of AIDS-related deaths. Although there is increased access and use of antiretroviral drugs, children under 1\u202fyear in resource-poor settings with a high HIV disease burden remain vulnerable due to poor initiation of these critical interventions impeding progress to meet the 95\u201395\u201395 targets. There are renewed efforts to ensure that exposed children under 15\u202fyears are not left behind by scaling diagnostics and clinical management in the most affected communities. However, gaps remain in the integration of these services into maternal, child, and adolescent healthcare services within these communities, resulting in only 67% of HIV-exposed infants being tested within 2\u202fmonths of birth, globally in 2023. Consequently, only 29% of all exposed children under 15\u202fyears were initiated in antiretroviral treatment before their 5th birthday in 2023. There are successes for adults aged 15\u202fyears and above, but children under 15\u202fyears risk being left behind in achieving the 95\u201395\u201395 targets. In this study, we review efforts made to reduce these substantial regional variations when comparing progress made between children under 15\u202fyears and adults and highlight gaps that might impede achievement of the 95\u201395\u201395 targets among children.<\/jats:p>","DOI":"10.3389\/fpubh.2025.1565242","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:10:50Z","timestamp":1745899850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets"],"prefix":"10.3389","volume":"13","author":[{"given":"Benard W.","family":"Kulohoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette S. A.","family":"Wesonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-030-14857-7_11","article-title":"Prioritising health systems to achieve SDGs in Africa: a review of scientific evidence","volume-title":"Africa and the sustainable development goals. Sustainable development goals series","author":"Wesonga","year":"2020"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2352-3018(20)30309-X","article-title":"Stigma reduction: an essential ingredient to ending AIDS by 2030","volume":"8","author":"Nyblade","year":"2021","journal-title":"Lancet HIV"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(10)60830-6","article-title":"People who use drugs, HIV, and human rights","volume":"376","author":"Jurgens","year":"2010","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.12688\/f1000research.10876.1","article-title":"Recent advances in understanding HIV evolution","volume":"6","author":"Andrews","year":"2017","journal-title":"F1000Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1128\/JVI.00684-16","article-title":"HIV maintains an evolving and dispersed population in multiple tissues during suppressive combined antiretroviral therapy in individuals with cancer","volume":"90","author":"Rose","year":"2016","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","article-title":"Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women","volume":"391","author":"Bekker","year":"2024","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1089\/jwh.2018.7485","article-title":"Natural conception is safe for HIV-Serodiscordant couples with persistent suppressive antiretroviral therapy for the infected partner","volume":"28","author":"Baza","year":"2019","journal-title":"J Women\u2019s Health"},{"key":"ref8","year":"2024"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000003344","article-title":"Updated data and methods for the 2023 UNAIDS HIV estimates","volume":"95","author":"van Schalkwyk","year":"","journal-title":"JAIDS J Acquir Immune Deficiency Syndromes"},{"key":"ref10","year":"2024"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0272405","DOI":"10.1371\/journal.pone.0272405","article-title":"Achieving the 95 95 95 targets for all: a pathway to ending AIDS","volume":"17","author":"Ambrose","year":"2022","journal-title":"PLoS One"},{"key":"ref12","year":""},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/s2352-3018(24)00003-1","article-title":"Progress towards the UNAIDS 95-95-95 targets in the fifth Botswana AIDS impact survey (BAIS V 2021): a nationally representative survey","volume":"11","author":"Mine","year":"2024","journal-title":"Lancet HIV"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1273720","DOI":"10.3389\/fpubh.2023.1273720","article-title":"Redefining HIV care: a path toward sustainability post-UNAIDS 95-95-95 targets","volume":"11","author":"Musuka","year":"2023","journal-title":"Front Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010901","article-title":"High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa","volume":"97","author":"Chandiwana","year":"2018","journal-title":"Medicine"},{"key":"ref16","year":"2024"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e0308167","DOI":"10.1371\/journal.pone.0308167","article-title":"Trend, spatial distribution, and factors associated with HIV testing uptake among pregnant women in Ethiopia, based on 2005\u20132016 Ethiopia demographic and health survey: a multivariate decomposition analysis and geographically weighted regression","volume":"19","author":"Misganie","year":"2024","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2023.5076","article-title":"Antiretroviral treatment of HIV\/AIDS during pregnancy","volume":"329","author":"Eke","year":"2023","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/COH.0000000000000027","article-title":"Immediate antiretroviral therapy in young HIV-infected children","volume":"9","author":"Collins","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0304239","DOI":"10.1371\/journal.pone.0304239","article-title":"Incidence of lost to follow up among HIV-positive children on antiretroviral therapy in Ethiopia: systematic review and meta-analysis","volume":"19","author":"Dememew","year":"2024","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/QAI.0000000000003487","article-title":"Outcomes after loss to follow-up for pregnant and postpartum women living with HIV and their children in Kenya: a prospective cohort study","volume":"97","author":"Humphrey","year":"2024","journal-title":"J Acq Immune Deficiency Syndromes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0002437","DOI":"10.1371\/journal.pgph.0002437","article-title":"Re-engagement and retention in HIV care after preventive default tracking in a cohort of HIV-infected patients in rural Malawi: a mixed-methods study","volume":"4","author":"Togun","year":"2024","journal-title":"PLoS Global Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12911-021-01718-0","article-title":"A clinical decision support system is associated with reduced loss to follow-up among patients receiving HIV treatment in Kenya: a cluster randomized trial","volume":"21","author":"Oluoch","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/09540121.2022.2041164","article-title":"Financial incentives to improve re-engagement in HIV care: results from a randomized pilot study","volume":"35","author":"H\u00e9mono","year":"2022","journal-title":"AIDS Care"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/INF.0000000000002612","article-title":"Pediatric HIV care cascade in southern Mozambique: missed opportunities for early ART and re-engagement in care","volume":"39","author":"Fern\u00e1ndez-Luis","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","year":"2024"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12887-022-03697-1","article-title":"Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia: a case-control study","volume":"22","author":"Mengesha","year":"2022","journal-title":"BMC Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/HIV.S407105","article-title":"Children\u2019s adherence to antiretroviral therapy and associated factors: multicenter cross-sectional study","volume":"15","author":"Gemechu","year":"2023","journal-title":"HIV\/AIDS Res Palliative Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/cid\/ciac059","article-title":"Prevalence and correlates of viral load suppression and human immunodeficiency virus (HIV) drug resistance among children and adolescents in south Rift Valley and Kisumu, Kenya","volume":"75","author":"Tsikhutsu","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0000418","DOI":"10.1371\/journal.pgph.0000418","article-title":"Factors associated with antiretroviral therapy adherence among adolescents living with HIV in the era of isoniazid preventive therapy as part of HIV care","volume":"2","author":"Kerkhoff","year":"2022","journal-title":"PLoS Global Public Health"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/apc.2011.0083","article-title":"Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study","volume":"25","author":"Fetzer","year":"2011","journal-title":"AIDS Patient Care STDs"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0295227","DOI":"10.1371\/journal.pone.0295227","article-title":"The level of antiretroviral therapy (ART) adherence among orphan children and adolescents living with HIV\/AIDS: a systematic review and meta-analysis","volume":"19","author":"Isaakidis","year":"2024","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2458-14-365","article-title":"Adherence to antiretroviral therapy and its associated factors among children at south Wollo zone hospitals, Northeast Ethiopia: a cross-sectional study","volume":"14","author":"Arage","year":"2014","journal-title":"BMC Public Health"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"934412","DOI":"10.3389\/fpubh.2022.934412","article-title":"Rates and determinants of retention on ART among orphans and vulnerable children living with HIV in Tanzania","volume":"10","author":"Charles","year":"2022","journal-title":"Front Public Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1654938","article-title":"The need for pediatric formulations to treat children with HIV","volume":"2016","author":"Schlatter","year":"2016","journal-title":"AIDS Res Treatment"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5863\/1551-6776-26.8.783","article-title":"Antiretroviral therapy in children and adolescents: a look into modern single tablet regimens","volume":"26","author":"Lee","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e2217","DOI":"10.1093\/cid\/ciaa1068","article-title":"Drug resistance mutations among south African children living with HIV on WHO-recommended ART regimens","volume":"73","author":"Hackett","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12879-021-05905-2","article-title":"Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa","volume":"21","author":"Obasa","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/v12090936","article-title":"Structural comparison of diverse HIV-1 subtypes using molecular modelling and docking analyses of integrase inhibitors","volume":"12","author":"Isaacs","year":"2020","journal-title":"Viruses"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e68784","DOI":"10.7759\/cureus.68784","article-title":"A comprehensive review of HIV-associated tuberculosis: clinical challenges and advances in management","volume":"16","author":"Patel","year":"2024","journal-title":"Cureus"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S2352-4642(20)30037-7","article-title":"Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy","volume":"4","author":"Frigati","year":"2020","journal-title":"Lancet Child Adolescent Health"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1016\/S2352-3018(24)00273-X","article-title":"Lenacapavir licenses will not deliver on all opportunities","volume":"11","year":"2024","journal-title":"Lancet HIV"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/S2352-3018(24)00239-X","article-title":"Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis","volume":"11","author":"Wu","year":"2024","journal-title":"Lancet HIV"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"q2254","DOI":"10.1136\/bmj.q2254","article-title":"Lenacapavir: a giant step forward in HIV prevention\u2014but a missed opportunity for achieving equity and access","volume":"387","author":"Yamey","year":"2024","journal-title":"BMJ"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e1008983","DOI":"10.1371\/journal.ppat.1008983","article-title":"Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence","volume":"16","author":"Sheppard","year":"2020","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/jama.2015.1382","article-title":"Infant HIV-1 Vaccines","volume":"313","author":"Fouda","year":"2015","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.adu8279","article-title":"Children are left behind in Congo\u2019s mpox vaccination drive","volume":"386","author":"Cohen","year":"2024","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e000092","DOI":"10.1136\/bmjpo-2017-000092","article-title":"Peripheral blood RNA gene expression in children with pneumococcal meningitis: a prospective case-control study","volume":"1","author":"Kulohoma","year":"2017","journal-title":"BMJ Paediatr Open"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e72476","DOI":"10.7759\/cureus.72476","article-title":"Bridging data gaps: predicting sub-national maternal mortality rates in Kenyan using machine learning models","volume":"16","author":"Mwaura","year":"2024","journal-title":"Cureus"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.26502\/fjwhd.2644-288400118","article-title":"Sub-National Disparities in indicators of maternal mortality in Kenya: insights from demographic health surveys towards attaining SDG 3","volume":"7","author":"Mwaura","year":"2024","journal-title":"J Women's Health Dev"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1097\/MS9.0000000000002154","article-title":"Strengthening laboratory systems for ensuring accurate diagnoses in mother-to-child transmission (MTCT) prevention programs in Uganda: a narrative review","volume":"86","author":"Ifeanyi Obeagu","year":"2024","journal-title":"Ann Med Surg"},{"key":"ref52","author":"Wexler","year":"2024"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21955\/aasopenres.1115135.1","article-title":"Securing Africa\u2019s health sovereignty: why investing in science and innovation matters","volume":"3","author":"Mugabe","year":"2020","journal-title":"AAS Open Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"779778","DOI":"10.3389\/fpubh.2022.779778","article-title":"The impact of armed conflict on the prevalence and transmission dynamics of HIV infection in Libya","volume":"10","author":"Daw","year":"2022","journal-title":"Front Public Health"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5334\/aogh.3243","article-title":"High HIV detection in a tertiary Facility in Liberia: implications and opportunities","volume":"87","author":"Ogbuagu","year":"2021","journal-title":"Ann Glob Health"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1565242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:10:53Z","timestamp":1745899853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1565242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":55,"alternative-id":["10.3389\/fpubh.2025.1565242"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1565242","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1565242"}}